Embryo Transfer Clinical Trial
Official title:
Frozen-Thawed Embryo Transfers: a Comparison Between Natural Cycles With Spontaneous or Induced Ovulation
In recent years, frozen-thawed embryo transfer procedure (FET) has been widely used to
increase the cumulative pregnancy rate per IVF-cycle: which is the best preparation protocol
remains a matter of debate.
A retrospective analysis was conducted between 2012-2017. The aim was comparing clinical
pregnancy rate (CPR) of pure natural cycle frozen-thawed embryo transfer (NC-FET) versus
natural cycle frozen-thawed embryo transfer with hCG-triggered ovulation (mNC-FET).
Compared to repeated oocyte retrieval procedure, frozen-thawed embryo transfer (FET) has been
widely used to increase the cumulative pregnancy rate per IVF-cycle, with demonstrated
superiority in preventing ovarian hyperstimulation syndrome and improving cost-efficiency and
time to pregnancy.
It is controversial whether triggering ovulation of the dominant follicle using human
chorionic gonadotrophin (hCG) may benefit or reduce embryo implantation, when compared with a
natural cycle environment. Unfavourable clinical outcomes of controlled ovarian stimulation
have been reported by recently published studies, compared to the spontaneous LH surge.
This study aimed to compare the effectiveness in terms of better clinical pregnancy rates
(CPR) of pure natural cycle frozen-thawed embryo transfer (NC-FET) versus natural cycle
frozen-thawed embryo transfer modified by HCG administration\with hCG-triggered ovulation
(mNC-FET).
A retrospective analysis was conducted between 2012-2017. In patients with regular ovulatory
cycles, the timing of embryo thawing and transferring was based on spontaneous LH surge
(NC-FET). Patients attended for ultrasound evaluation of the dominant follicle from Day 8 to
10 of their menstrual cycle (depending on cycle length), detecting luteinizing hormone (LH)
surge in urine/ taking an ovulation test for urinary LH measurement. In selected cases, a
serum assays of LH, progesterone and estradioI has been further obtained. When the
endometrial thickness reached 8 mm and dominant follicle 16-20 mm in diameter, hCG was
administered in absence of urinary LH surge. Embryo thawing and transfer was planned 7 days
after LH surge or HCG administration, whether G5 or G6 blastocyst. Exogenous progesterone
supplementation started 2 days after hCG administration versus the same day of embryo
transfer procedure in NC- ET. To limit potential confounders, only single blastocyst transfer
cycles were included, vitrified on Days 5 or 6, excluding PGT-a (Pre Gestational Test for
aneuploydia) cycles and cleavage stage embryo transfers. A unilevel and multi level logistic
regression analysis was conducted using Stata Software versione15.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03642665 -
Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer
|
Phase 4 | |
Completed |
NCT01919502 -
Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment
|
N/A | |
Completed |
NCT03292770 -
Mucus Removal Before Embryo Transfer
|
N/A | |
Recruiting |
NCT06134609 -
Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer?
|
N/A | |
Completed |
NCT03040830 -
Effect of Timing Progesterone Luteal Support on Embryo Transfer
|
Phase 4 | |
Recruiting |
NCT04725864 -
Progesterone as Luteal Support in Frozen IVF Natural Cycles
|
Phase 4 | |
Recruiting |
NCT04619524 -
Biomarkers of Endometrial Receptivity
|
N/A | |
Completed |
NCT04297553 -
Fresh Versus Freeze-only After CAPA IVM on PCOS Patients
|
N/A | |
Completed |
NCT01846403 -
Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting
|
N/A | |
Completed |
NCT02703181 -
Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers
|
Phase 1 | |
Recruiting |
NCT02825290 -
Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study
|
Phase 4 | |
Completed |
NCT01863680 -
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
|
Phase 3 | |
Terminated |
NCT03386227 -
Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT
|
N/A | |
Recruiting |
NCT04124913 -
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
|
Phase 4 | |
Completed |
NCT05364528 -
Pregnancy Rate in Direct Versus Afterload Technique of Embryo Transfer
|
||
Completed |
NCT04253470 -
Debate on Progesterone Elevation on the Day of Triggering
|
||
Completed |
NCT02257359 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT06084793 -
Music for Anxiety in Embryo Transfers
|
N/A | |
Completed |
NCT03201783 -
Immediate Versus Delayed FET Following a Stimulated IVF Cycle
|
N/A | |
Recruiting |
NCT03518528 -
Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer
|